Literature DB >> 17443451

[Is quality of life in dementia patients validly estimable?].

Christiane Roick1, Andreas Hinz, Hermann-Josef Gertz.   

Abstract

OBJECTIVE: The measurement of quality of life (QoL) in dementia is a methodological challenge because of the patients' cognitive impairment and anosognosia. This review gives an overview of the possibilities and methodological problems of QoL measurement in dementia patients.
METHODS: With literature searches conducted in PubMed and Web of Science 12 dementia-specific QoL-measures were identified.
RESULTS: Most authors agreed that patients with mild to moderate dementia themselves can validly and reliably estimate their QoL. But with increasing severity of the disease, patient ratings must mostly be replaced by proxy ratings. The latter are especially essential in longitudinal studies, but are not a satisfying substitute for the patients' perspective. Thus, the influence of depression and care-related burden on the proxies' QoL-ratings should be controlled.
CONCLUSIONS: QoL-instruments, applicable to all stages of dementia should be preferred, because longitudinal QoL-measures are more meaningful than cross sectional analyses. The patients' perspective should be taken into consideration as long as possible, since proxies assess the QoL of dementia patients differently from the persons affected.

Entities:  

Mesh:

Year:  2007        PMID: 17443451     DOI: 10.1055/s-2006-952012

Source DB:  PubMed          Journal:  Psychiatr Prax        ISSN: 0303-4259


  3 in total

1.  [Quality of life in mild cognitive impairment, patients with different stages of Alzheimer disease and healthy control subjects].

Authors:  Elisabeth M Weiss; Ilona Papousek; Andreas Fink; Theresa Matt; Josef Marksteiner; Eberhard A Deisenhammer
Journal:  Neuropsychiatr       Date:  2012-07-27

Review 2.  [Critical observations on measuring quality of life of persons suffering from dementia].

Authors:  H-J Gertz; M Berwig
Journal:  Nervenarzt       Date:  2008-09       Impact factor: 1.214

3.  Study protocol: Randomised controlled trial to evaluate the impact of an educational programme on Alzheimer's disease patients' quality of life.

Authors:  Hélène Villars; Virginie Gardette; Amélie Perrin; Christophe Hein; Sophie Elmalem; Eva de Peretti; Audrey Zueras; Bruno Vellas; Fati Nourhashémi
Journal:  Alzheimers Res Ther       Date:  2014-10-27       Impact factor: 6.982

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.